Morepen Laboratories has informed that the Board of Directors of the company in their meeting held today Saturday, 5th August, 2023 (commenced at 11:15 AM and concluded at 2:15 PM), have, considered and approved Un-audited standalone and consolidated financial results of the company for the quarter ended 30th June, 2023. Pursuant to Regulation 33 of the SEBI Listing Regulations, a copy of the ‘Results’ along with Limited Review Report of the Statutory Auditors of the company, are enclosed; Re-appointment of Sushil Suri (DIN:00012028) as the Chairman & Managing Director of the company for a further period of 3 years, effective from 20th October, 2023, subject to the approval of the members in the ensuing Annual General Meeting of the company.
The above information is a part of company’s filings submitted to BSE.
